×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

La SFCO présente : un webinar autour du cancer de l'ovaire

Programme

Modérateur: Pr Fabrice Lécuru

18:00
Les données actuelles françaises
Dr Marie Osdoit
 
18:20
Les critères de qualité en chirurgie
Pr Denis Querleu (ESGO)
 
18:40
Le parcours de soins
Dr Manuel Rodrigues
 
19:00 Réponses aux questions et Débat/Discussion


 

Shooting date : 2020-06-24
Last update : 2020-06-25
7 comments
Join the Discussion
See previous comments (3)
  • lylia H. @Michel L.
    Dr. Manuel Rodrigues:
    Non. Si la patiente a été sous antiPARP en 1ere ligne ("adjuvant") et qu'elle rechute à plus de 6 mois, il n'y a pas de preuve de l'intérêt de remettre sous antiPARP. Par contre il y a l'essai OREO (remise sous PARP ou placebo) qui évalue cette question actuellement et bientôt d'autres essais

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • lylia H. @Mohamed K
      Dr. Denis Querieu
      ils sont fondés sur la littérature, et finalement pas trop exigeants (20 par an c'est 2 par mois environ)

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • lylia H.
        @Eno L
        Dr. Denis Querieu :
        réglementations trop différentes pour légiférer facilement ; en fait, il existe déjà fellowship ESGO 2 ans et examen ESGO et en conséquence un titre de gynéco oncologue européen

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        • lylia H. @Yann R
          Dr. Manuel Rodrigues
          très bonne question. C'est majeur car cette prise en charge est un vrai rouleau compresseur mais on manque de moyens humains

            Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
            Your browser doesn't have Flash, Silverlight or HTML5 support.


          • lylia H. @Carlos M.
            Dr; Manuel Rodrigues
            Les PARPinh sont des drogues indispensables si BRCAm. Chez les BRCA sauvages c'est important aussi mais moins. A ce jour il faut etre prudent, ces drogues sont utiles pendant une ligne. Il n'y a aucune preuve que de redonner un PARP soit utile => essai OREO

              Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
              Your browser doesn't have Flash, Silverlight or HTML5 support.


            • lylia H. @Florient M
              Dr. Manuel Rodrigues
              dans le doute oui, il y a eu des cas. Ne serait ce que sur un mauvais echantillonage anapath. Il n'y a guère que les mucineux évidents pour lesquels on a pas de BRCA

                Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
                Your browser doesn't have Flash, Silverlight or HTML5 support.


              • lylia H. @ Melanie R
                Dr. Manuel Rodrigues
                2 ans

                  Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
                  Your browser doesn't have Flash, Silverlight or HTML5 support.


                Suggestions

                Monday, May 13th 2024 from 06pm to 07:30pm (GMT+2)
                Honolulu : Monday, May 13th 2024 from 07am to 08:30am (GMT+2)
                San Francisco : Monday, May 13th 2024 from 10am to 11:30am (GMT+2)
                New York : Monday, May 13th 2024 from 01pm to 02:30pm (GMT+2)
                Buenos Aires : Monday, May 13th 2024 from 02pm to 03:30pm (GMT+2)
                Reykjavik : Monday, May 13th 2024 from 05pm to 06:30pm (GMT+2)
                London / Dublin : Monday, May 13th 2024 from 06pm to 07:30pm (GMT+2)
                Paris / Berlin : Monday, May 13th 2024 from 07pm to 08:30pm (GMT+2)
                Istanbul : Monday, May 13th 2024 from 08pm to 09:30pm (GMT+2)
                Moscou / Dubaï : Monday, May 13th 2024 from 09pm to 10:30pm (GMT+2)
                Bangkok : Tuesday, May 14th 2024 from 12am to 01:30am (GMT+2)
                Shanghai : Tuesday, May 14th 2024 from 01am to 02:30am (GMT+2)
                Tokyo : Tuesday, May 14th 2024 from 02am to 03:30am (GMT+2)
                Sydney : Tuesday, May 14th 2024 from 04am to 05:30am (GMT+2)
                Wellington : Tuesday, May 14th 2024 from 06am to 07:30am (GMT+2)

                Nouvelles autorisations en chirurgie des cancers :

                Où en est-on 2 ans après la publication du décret Véran ?

                Share
                Tuesday, March 22nd 2022 from 09am to 05pm (GMT+1)
                Honolulu : Monday, March 21st 2022 from 10pm to 06am (GMT+1)
                San Francisco : Tuesday, March 22nd 2022 from 12am to 08am (GMT+1)
                New York : Tuesday, March 22nd 2022 from 03am to 11am (GMT+1)
                Buenos Aires : Tuesday, March 22nd 2022 from 05am to 01pm (GMT+1)
                London / Dublin : Tuesday, March 22nd 2022 from 08am to 04pm (GMT+1)
                Paris / Berlin : Tuesday, March 22nd 2022 from 09am to 05pm (GMT+1)
                Istanbul : Tuesday, March 22nd 2022 from 10am to 06pm (GMT+1)
                Moscou / Dubaï : Tuesday, March 22nd 2022 from 12pm to 08pm (GMT+1)
                Bangkok : Tuesday, March 22nd 2022 from 03pm to 11pm (GMT+1)
                Shanghai : Tuesday, March 22nd 2022 from 04pm to 12am (GMT+1)
                Tokyo : Tuesday, March 22nd 2022 from 05pm to 01am (GMT+1)
                Sydney : Tuesday, March 22nd 2022 from 06pm to 02am (GMT+1)
                Wellington : Tuesday, March 22nd 2022 from 08pm to 04am (GMT+1)

                Chirurgie ouverte et chirurgie laparoscopique avancées en Oncologie Gynécologique

                Formation théorique et chirurgie Live du bloc opératoire

                Share
                Thursday, November 17th 2022 from 06pm to 07:30pm (GMT+1)
                Honolulu : Thursday, November 17th 2022 from 07am to 08:30am (GMT+1)
                San Francisco : Thursday, November 17th 2022 from 09am to 10:30am (GMT+1)
                New York : Thursday, November 17th 2022 from 12pm to 01:30pm (GMT+1)
                Buenos Aires : Thursday, November 17th 2022 from 02pm to 03:30pm (GMT+1)
                London / Dublin : Thursday, November 17th 2022 from 05pm to 06:30pm (GMT+1)
                Paris / Berlin : Thursday, November 17th 2022 from 06pm to 07:30pm (GMT+1)
                Istanbul : Thursday, November 17th 2022 from 07pm to 08:30pm (GMT+1)
                Moscou / Dubaï : Thursday, November 17th 2022 from 09pm to 10:30pm (GMT+1)
                Bangkok : Friday, November 18th 2022 from 12am to 01:30am (GMT+1)
                Shanghai : Friday, November 18th 2022 from 01am to 02:30am (GMT+1)
                Tokyo : Friday, November 18th 2022 from 02am to 03:30am (GMT+1)
                Sydney : Friday, November 18th 2022 from 03am to 04:30am (GMT+1)
                Wellington : Friday, November 18th 2022 from 05am to 06:30am (GMT+1)

                Visible Patient : comment la planification 3D peut aider le chirurgien oncologue au quotidien ?

                Share
                Tuesday, March 12th 2024 from 09am to 05pm (GMT+1)
                Honolulu : Monday, March 11th 2024 from 10pm to 06am (GMT+1)
                San Francisco : Tuesday, March 12th 2024 from 12am to 08am (GMT+1)
                New York : Tuesday, March 12th 2024 from 03am to 11am (GMT+1)
                Buenos Aires : Tuesday, March 12th 2024 from 05am to 01pm (GMT+1)
                London / Dublin : Tuesday, March 12th 2024 from 08am to 04pm (GMT+1)
                Paris / Berlin : Tuesday, March 12th 2024 from 09am to 05pm (GMT+1)
                Istanbul : Tuesday, March 12th 2024 from 10am to 06pm (GMT+1)
                Moscou / Dubaï : Tuesday, March 12th 2024 from 12pm to 08pm (GMT+1)
                Bangkok : Tuesday, March 12th 2024 from 03pm to 11pm (GMT+1)
                Shanghai : Tuesday, March 12th 2024 from 04pm to 12am (GMT+1)
                Tokyo : Tuesday, March 12th 2024 from 05pm to 01am (GMT+1)
                Sydney : Tuesday, March 12th 2024 from 06pm to 02am (GMT+1)
                Wellington : Tuesday, March 12th 2024 from 08pm to 04am (GMT+1)

                Chirurgie ouverte et chirurgie laparoscopique avancées en Oncologie Gynécologique

                Formation théorique et chirurgie Live du bloc opératoire

                Share
                Scroll Up